Effect of PPAR-gama agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus

Abstract

Diabetes mellitus, endothelial dysfunction, thiazolidinediones, cardiovascular risk, adipocyte-derived hormones